Genetic Testing May Help Reduce Breast Cancer Disparities for African American Women
- 5 March 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 112 (12), 1179-1180
- https://doi.org/10.1093/jnci/djaa042
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American WomenJNCI Journal of the National Cancer Institute, 2020
- Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing ScreeningJAMA, 2020
- Supplemental MRI Screening for Women with Extremely Dense Breast TissueThe New England Journal of Medicine, 2019
- Trends in BRCA Test Utilization in an Integrated Health System, 2005–2015JNCI Journal of the National Cancer Institute, 2019
- Abbreviated Magnetic Resonance Imaging (MRI) for Breast Cancer Screening: Rationale, Concept, and Transfer to Clinical PracticeAnnual Review of Medicine, 2019
- National Estimates of Genetic Testing in Women With a History of Breast or Ovarian CancerJournal of Clinical Oncology, 2017
- Changes in the racial disparity in breast cancer mortality in the ten US cities with the largest African American populations from 1999 to 2013: The reduction in breast cancer mortality disparity in ChicagoCancer Causes & Control, 2017
- Health Care Segregation, Physician Recommendation, and Racial Disparities inBRCA1/2Testing Among Women With Breast CancerJournal of Clinical Oncology, 2016
- Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health systemGenetics in Medicine, 2015
- Racial Differences in the Use of BRCA1/2 Testing Among Women With a Family History of Breast or Ovarian CancerJAMA, 2005